SHOT Safety Notice 03: Safe, appropriate, and timely administration of anti-D immunoglobulin during the perinatal period has been released

With anti-D Ig errors accounting for 22% to 24% of the total errors (excluding near misses) analysed by SHOT annually, we are reaching out to you with this safety notice covering ‘Safe, appropriate, and timely administration of anti-D Immunoglobulin during the perinatal period’ to encourage a review of local policies, processes and practices in place and address gaps to enhance patient safety.

This has been drafted by relevant SHOT Working Expert Group members and has been reviewed and approved by Royal College of Obstetricians & Gynaecologists and by the Royal College of Midwives.

We encourage you to liaise with relevant teams locally, carry out a gap analysis using the safety notice (also available as an Excel spreadsheet in an accessible format) and map out actions needed to address gaps identified and enhance safety.

To access the Safety Notice: Safe, appropriate, and timely administration of anti-D immunoglobulin during the perinatal period

To access the gap analysis in Excel: Gap analysis

To access the gap analysis in Word: Gap Analysis